Last reviewed · How we verify

NCT05931198: MYARM

Several Studys Showed That Upper Limb Amputated Patients Are Able to Experience the Illusion of the Rubber Hand Whith Prosthesis: We Want to go Futher by Comparing the Strength of the Incorporation According to the Type of Prosthesis Using the Illusion of the Rubber Hand With Prothesis

Recruiting now NA Last updated 8 October 2024
What this trial tests

NA trial testing Modified illusion of the rubber (syncrhone) in Appropriate Affect in 36 participants. Currently enrolling.

Timeline
12 September 2023
Primary endpoint
15 May 2024
1 June 2025

Quick facts

Lead sponsorInstitut Robert Merle d'aubigné
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposeother
Enrollment36
Start date12 September 2023
Primary completion15 May 2024
Estimated completion1 June 2025
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

Institut Robert Merle d'aubigné

Who can join

18 and older, any sex, with Appropriate Affect. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this observational study is to compare the strength of the incorporation according to the type of prosthesis (aesthetic, mechanical, myoelectric) with the experience the illusion of the rubber hand. The investigators will replace is the rubber by the patient's prothesis. The population will be people with upper arm amputation above the hand and they will be their own comparation. Participants will do the the experience the illusion of the rubber hand in asynchronic and synchronic way and to answer questionnaries.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Institut Robert Merle d'aubigné trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05931198.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing